Daily Expert News
No Result
View All Result
Sunday, July 3, 2022
  • Home
  • World
  • Economy
  • Business
  • Markets
  • Arts & Culture
  • Education & Career
  • India
  • Politics
  • Top Stories
Daily Expert News
  • Home
  • World
  • Economy
  • Business
  • Markets
  • Arts & Culture
  • Education & Career
  • India
  • Politics
  • Top Stories
No Result
View All Result
Daily Expert News
No Result
View All Result
  • Home
  • World
  • Economy
  • Business
  • Markets
  • Arts & Culture
  • Education & Career
  • India
  • Politics
  • Top Stories
Home Uncategorized

Pfizer is expected to ask the FDA to approve its Covid vaccine for children under the age of 5.

by Nick Erickson
February 1, 2022
in Uncategorized
130 3
0
Pfizer is expected to ask the FDA to approve its Covid vaccine for children under the age of 5.
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT


“Unfortunately, we are seeing an increase in hospital admissions for children aged 0 to 4, children who are not currently eligible for Covid-19 vaccination,” said Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, told reporters. month. She said the high transfer rate of the Omicron variant was probably to blame.

The coronavirus pandemic: important things to know


The FDA and CDC are expected to convene both committees of outside vaccine advisors before making a decision on whether to release the injections. That gives independent experts the opportunity to discuss the data the companies have collected. Most senior federal health officials strongly support the strategy, two officials said, but they want the outside experts to speak their mind.

Kathrin Jansen, Pfizer’s chief of vaccine research, said in December that the company would seek FDA approval for three doses for young children, a strategy she says would enable “a consistent three-dose vaccine approach for all ages.” The company changed its plan as the FDA pushed for more urgent action, two people said. If allowed, young children will receive their second dose three weeks after the first and a third dose two months after that.

The CDC now considers three doses of the vaccine an “up-to-date” regimen for those eligible for additional injections, including those 12 years and older. Regulators have authorized booster doses given five months after the second injection. Children from 5 years of age with a weakened immune system are also eligible for additional injections.

The deliberations in the coming weeks could affect how quickly parents get their youngest children vaccinated. The vaccination rate of the 28 million American children between the ages of 5 and 11 remains even lower than health experts had feared. About 30 percent of children in that age group have received at least one dose, according to CDC data.

The reasons why more young children have not received injections vary. Some parents are put off by misinformation about the vaccine; others do not believe the virus poses a sufficient threat to vaccinate their children. Some simply haven’t found the time to take their children in for injections yet, health officials report.

The CDC published a study in late December that found very few reports of serious problems in children ages 5 to 11 who had received Pfizer-BioNTech injections. Another study of hundreds of pediatric hospitalizations in six cities last summer, released by the agency, found that nearly all children who became seriously ill had not been fully vaccinated.

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Tags: ageapproveChildrenCovidDailyExpertNewsexpectedFDAPfizervaccine

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe
ADVERTISEMENT

Related Posts

Young Jugraj Singh beats hat-trick as India beats South Africa 10-2 in FIH Pro League Hockey | Hockey News
Uncategorized

Harmanpreet Singh scores four goals in India’s 10-2 smashing of South Africa in FIH Pro League Hockey | Hockey News

February 13, 2022
Review: An audition season begins at the Philharmonic
Uncategorized

Review: An audition season begins at the Philharmonic

February 13, 2022
Good way to good taste
Uncategorized

Good way to good taste

February 13, 2022
Good way to good taste
Uncategorized

Good way to good taste

February 13, 2022
What to cook this week
Uncategorized

What to cook this week

February 13, 2022
Sigal Barsade, 56, dies; Argued it's okay to show emotions at work
Uncategorized

Sigal Barsade, 56, dies; Argued it’s okay to show emotions at work

February 13, 2022
  • Trending
  • Comments
  • Latest
This optical illusion has a revelation about your brain and eyes

This optical illusion has a revelation about your brain and eyes

June 6, 2022
NDTV Coronavirus

Viral video: Chinese woman pinned down, Covid test carried out by force

May 5, 2022
Hundreds In Sarees At UK

Hundreds of sarees at Britain’s Royal Ascot Horse Race to help Indian weavers

June 16, 2022
Sabrina's parents love her. But the meltdowns are too many.

Sabrina’s parents love her. But the meltdowns are too many.

June 1, 2022

Hello world!

0
NDTV News

IT startup Fareye aims to change Unicorn within a year, founder says

0
How did Stephanie Murphy, a holdout on Biden's agenda, help save it?

How did Stephanie Murphy, a holdout on Biden’s agenda, help save it?

0
How did Stephanie Murphy, a holdout on Biden's agenda, help save it?

How did Stephanie Murphy, a holdout on Biden’s agenda, help save it?

0
A mermaid makes for a strange kind of immigrant

A mermaid makes for a strange kind of immigrant

July 3, 2022
ENG vs IND, 5th Test: Skipper Jasprit Bumrah leads India from the front, 5-down England Trail with 332 on Day 2 | Cricket News

India vs England Edgbaston 5th Test Day 3 LIVE Score Updates: India Eye to Continue Dominance in Birmingham | Cricket News

July 3, 2022
Israel Says It Will Test Bullet That Killed Reporter, Palestine Disagrees

Israel says it will test bullet that killed reporter, Palestine disagrees

July 3, 2022
Maldives build floating city to accommodate 20,000 people by 2027

Maldives build floating city to accommodate 20,000 people by 2027

July 3, 2022
ADVERTISEMENT

Recent News

A mermaid makes for a strange kind of immigrant

A mermaid makes for a strange kind of immigrant

July 3, 2022
ENG vs IND, 5th Test: Skipper Jasprit Bumrah leads India from the front, 5-down England Trail with 332 on Day 2 | Cricket News

India vs England Edgbaston 5th Test Day 3 LIVE Score Updates: India Eye to Continue Dominance in Birmingham | Cricket News

July 3, 2022

Categories

  • Africa
  • Americas
  • art-design
  • Arts
  • Asia Pacific
  • Astrology News
  • books
  • Books News
  • Business
  • Cricket
  • Cryptocurrency
  • Dance
  • Dining and Wine
  • Economy
  • Education & Career
  • Europe
  • Fashion
  • Food
  • Football
  • Gadget
  • Gaming
  • Golf
  • Health
  • Hot News
  • India
  • Indians Abroad
  • Lifestyle
  • Markets
  • Middle East
  • Most Shared
  • Motorsport
  • Movie
  • Music
  • New York
  • Opinion
  • Politics
  • press release
  • Real Estate
  • Review
  • Science & Space
  • Sports
  • Sunday Book Review
  • Tax News
  • Technology
  • Television
  • Tennis
  • Theater
  • Top Movie Reviews
  • Top Stories
  • Travel
  • Uncategorized
  • Web Series
  • World

Site Navigation

  • Home
  • Advertisement
  • Contact Us
  • Privacy & Policy
  • Other Links

We bring you the Breaking News,Latest Stories,World News, Business News, Political News, Technology News, Science News, Entertainment News, Sports News, Opinion News and much more from all over the world

©Copyright DailyExpertNews 2022

No Result
View All Result
  • Contact Us
  • Home
  • Top Stories
  • World
  • Economy
  • Business
  • Opinion
  • Markets
  • India
  • Education & Career
  • Arts
  • Advertisement
  • Tax News
  • Markets

©Copyright DailyExpertNews 2022

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.